Table 4.
CcS/Dem series |
OcB/Dem series |
||||||||
---|---|---|---|---|---|---|---|---|---|
Strain | BALB/c | STS | CcS-5 | CcS-16 | Strain | O20 | B10 | OcB-9 | |
A. Gbp2b/Gbp1 uninfected | |||||||||
BALB/c | O20 | ||||||||
STS | 0.46 | B10 | 0.94 | ||||||
CcS-5 | 0.088 | 0.24 | B10.O20 | 0.85 | 0.66 | ||||
CcS-16 | 0.53 | 0.82 | 0.0022 | OcB-9 | 0.052 | 0.13 | 0.045 | ||
CcS-20 | 0.18 | 0.39 | 0.39 | 0.70 | OcB-43 | 0.63 | 0.45 | 0.19 | 0.010 |
B. Gbp2b/Gbp1 infected | |||||||||
BALB/c | O20 | ||||||||
STS | 0.072 | B10 | 0.43 | ||||||
CcS-5 | 0.21 | 0.31 | B10.O20 | 0.66 | 0.98 | ||||
CcS-16 | 0.000074 | 0.0022 | 0.0022 | OcB-9 | 0.054 | 0.0018 | 0.035 | ||
CcS-20 | 0.0085 | 0.14 | 0.073 | 0.0012 | OcB-43 | 0.49 | 0.042 | 0.40 | 0.014 |
C. Gbp5 uninfected | |||||||||
BALB/c | O20 | ||||||||
STS | 0.33 | B10 | 0.026 | ||||||
CcS-5 | 0.86 | 0.18 | B10.O20 | 0.0080 | 0.85 | ||||
CcS-16 | 0.46 | 0.94 | 0.041 | OcB-9 | 0.79 | 0.052 | 0.011 | ||
CcS-20 | 0.86 | 0.59 | 0.59 | 0.49 | OcB-43 | 0.073 | 0.14 | 0.19 | 0.030 |
D. Gbp5 infected | |||||||||
BALB/c | O20 | ||||||||
STS | 0.00030 | B10 | 0.069 | ||||||
CcS-5 | 0.0047 | 0.31 | B10.O20 | 0.026 | 0.45 | ||||
CcS-16 | 0.77 | 0.0022 | 0.0022 | OcB-9 | 0.78 | 0.54 | 0.33 | ||
CcS-20 | 0.011 | 0.84 | 0.95 | 0.0023 | OcB-43 | 0.23 | 0.13 | 0.062 | 0.95 |
A. Differences of Gbp2b/Gbp1 expression in uninfected liver; B. Differences of Gbp2b/Gbp1 expression in liver after 8 weeks of infection; C. Differences of Gbp5 expression in uninfected liver; D. Differences of Gbp5 expression in liver after 8 weeks of infection. Green: nominal (uncorrected) P value < 0.05; red: difference significant after correction for multiple testing at P < 0.05.